Coulter Partners at BIA Women in Biotech: Driving diversity in Life Sciences leadership

It was inspiring to hear from a remarkable line-up of female leaders and experts who shared their perspectives on how the next generation of Life Sciences investors can truly shift the dial on representation in Biotech Leadership.

A huge thank you to the BIA for organising such a crucial event. We particularly resonated with the discussions around the positive impact of diverse teams on performance and financial returns – a principle we champion in our work every day.

Highlights included powerful insights from:

• Aline Charpentier, Head of Innovation at Bruntwood SciTech, and Jane Wall, Managing Director at the BioIndustry Association (BIA), for their opening remarks.
• Elisa Petris, Co-founder and Board Member of Invest in Equity, on building a community for equitable change.
• The inspiring keynote from Dame Kate Bingham, Managing Partner at SV Health Investors, who shared SV's commitment to driving female leadership and highlighted initiatives like the Venture Capital Fellowship.
• The thoughtful panel discussion on building a more inclusive and effective biotech ecosystem, featuring Dame Kate Bingham, Lucy Edwardes Jones (BGF), Melisa Guven, Ph.D. (Monograph Capital), Caroline Haegeman (Athernal Bio / Delin Ventures), and Tej Panesar (Prism Ventures).

At Coulter Partners, we firmly believe that fostering diversity is not only the right approach but also a powerful driver of stronger business outcomes. We remain committed to supporting and advocating for greater female representation across the Biotech and Life Sciences sectors.

If you haven't already, we encourage you to check out the BIA's Women in Biotech Leadership Report!